The Founder's Guide to

Swanbridge Capital

Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.

Explore our founder-friendly guide and choose if you'd like to be connected.
We'll either provide a warm intro or provide you with more suitable alternatives.
Once you're put in touch, we'll provide you with helpful advice. It's 100% free.

Overview

Swanbridge Capital is a venture capital firm located in the Rotterdam region of the Netherlands, established in December 2016. The firm focuses on early-stage investments in the life sciences sector, particularly in therapeutics, diagnostics, and medical devices. With a fund size of €6.5 million, Swanbridge Capital aims to be the first external capital for startups at the proof-of-concept stage. The firm is backed by notable limited partners including Van Herk Investments, Erasmus University Medical Center, and the City of Rotterdam.

Since its inception, Swanbridge Capital has been dedicated to supporting innovative companies that are developing groundbreaking medical technologies. The firm not only provides financial investment but also offers access to a robust network and industry expertise to help portfolio companies navigate the complexities of the life sciences market. This active involvement is a key aspect of their investment strategy, ensuring that they contribute to the growth and success of their portfolio companies.

Learn More

Frequently Asked Questions

What are Swanbridge Capital's investment criteria?

Swanbridge Capital focuses on early-stage investments in the life sciences sector, specifically targeting pre-seed and seed stage companies. They look for startups that are at the proof-of-concept stage and developing innovative solutions in therapeutics, diagnostics, and medical devices.

How can I pitch Swanbridge Capital?

Founders interested in pitching Swanbridge Capital should prepare a detailed presentation that outlines their business model, market opportunity, and the innovative aspects of their product or service. While specific application channels are not disclosed, reaching out through professional networks or industry events may facilitate introductions.

What makes Swanbridge Capital different from other investors?

Swanbridge Capital distinguishes itself by providing active support to its portfolio companies beyond just financial investment. The firm offers access to a network of industry contacts and valuable knowledge, which can be crucial for early-stage companies navigating the complexities of the life sciences market.

What is the geographic focus of Swanbridge Capital?

The firm primarily invests in companies located in Europe, with a specific emphasis on the Rotterdam region and the broader Netherlands.

What is the typical check size for investments?

Swanbridge Capital operates with a fund size of €6.5 million, and while specific check sizes are not detailed, they typically invest at the pre-seed and seed stages, which often involves smaller initial investments to support early development.

What kind of post-investment involvement can founders expect?

Founders can expect Swanbridge Capital to take an active role in their business processes. This includes providing mentorship, strategic guidance, and access to a network of industry experts to help accelerate growth and navigate challenges.

All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.